5th Annual STING & TLR-Targeted Therapies Summit, San Diego, CA, June 19-20, 2024

Conference

genOway presentation

Event
-
June 19, 2024

June 19-20, 2024

Advancing the Next Wave of Immunotherapeutics: STING, TLR & Beyond

genOway's presentation on June 19, 2024 | 1 p.m. PDT:

Profiling STING and TLR-Targeted Therapies in Preclinical Models

  • Focus on STING humanized mouse models and BRGSF-HIS, hCD34+ reconstituted mice featuring human lymphoid and myeloid compartments
  • Characterization of the immune responses
  • Showcase of assessment of STING and TLR-targeting agents in these models

Get more information on the STING & TLR-Targeted Therapies Summit 2024 here

5th Annual STING & TLR-Targeted Therapies Summit, San Diego, CA, June 19-20, 2024

Get in touch

Let us know how we can help

Other news & events

genOway Shanghai at BIONNOVA West China Forum 2025
Conference
Event
-
Jul 2025
Read on
Tumour Models Nordics, Stockholm, Sweden, April 9-10, 2025
Conference
Event
-
Apr 2025
Read on
7th Treg-Directed Therapies Summit 2025, Boston, MA, March 25-27, 2025
Conference
Event
-
Mar 2025
Read on
NextGen Biomed 2025, London, UK, March 12-14, 2025
Conference
Event
-
Feb 2025
Read on
genOway signs a three-year contract with a global philanthropic organization supporting the development of infectious diseases therapies
Partnership
News
-
Feb 2025
Read on
Scientific excellence

From model design to experimental results
Featured in 600+ scientific articles

Collaborative approach

Collaboration with 17 Top Pharmas,
170+ Biotechs and 380+ Academic Institutions

Robust validation data on catalog models

Generated with biopharma partners and in-house

Innovative technologies

and guaranteed freedom to operate

Easy access to models

Models with certified health status from professional breeders in US and Europe